Keyphrases
Acquired Drug Resistance
33%
Biological Endpoints
33%
Cancer Clinical Trials
33%
Class-specific
33%
Clinical Setting
33%
Decitabine
33%
DNA Methyltransferase Inhibitor
33%
Dosing Schedule
33%
Drug Effects
33%
Drug Sensitivity
33%
Epigenetic Biomarkers
33%
Epigenetic Drugs
100%
Epigenetic Therapy
100%
Epigenome
33%
Epithelial Ovarian Cancer
100%
Gene Drug
33%
Gene Expression
33%
Ovarian Cancer
33%
Ovarian Cancer Cells
33%
Ovarian Cancer Patients
33%
Patient Response
33%
Phase I Trial
33%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
33%
Clinical Trial
33%
Decitabine
33%
Drug Resistance
33%
Ovary Cancer
100%
Ovary Carcinoma
100%
Phase I Trials
33%
Preclinical Study
33%